Literature DB >> 10381789

Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein.

J Nishino1, H Suzuki, D Sugiyama, T Kitazawa, K Ito, M Hanano, Y Sugiyama.   

Abstract

Transport characteristics of 17beta-estradiol 17beta-D-glucuronide (E217betaG), a dual substrate of the transporters for cellular uptake (organic anion-transporting polypeptide 1 or oatp1) and cellular excretion (multidrug resistance-associated protein 1or MRP1), in the rat choroid plexus were studied in vivo and in vitro. The uptake of E217betaG into isolated choroid plexus was mediated by an energy-dependent system with a Km of 3.4 microM. Together with the previous finding that oatp1 is localized on the apical membrane of choroid plexus, these results suggest that oatp1 is responsible for the uptake of this ligand. After intracerebroventricular administration, elimination of E217betaG from cerebrospinal fluid was probenecid sensitive and much more rapid than that of inulin; less than 2% of the administered E217betaG and 40 to 50% of inulin remained in the cerebrospinal fluid 20 min after intracerebroventricular administration. In addition, the amount of E217betaG associated with choroid plexus at 20 min was negligible, suggesting the presence of an efficient excretion system on the basolateral membrane of choroid plexus. Expression of MRP1 was detected in choroid plexus. Semiquantitative reverse transcription-polymerase chain reaction and Western blot analyses indicated that the expression level of MRP1 in choroid plexus is about four or five times higher than that in the lung, one of the tissues exhibiting high expression of MRP1. Together with the in vivo vectorial transport of E217betaG, these results can be accounted for by assuming that there is basolateral localization of MRP1 in choroid plexus. Combined, oatp1 and MRP1 may synergistically mediate the efficient transcellular transport of E217betaG across choroid plexus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381789

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Effect of probenecid on fluorescein transport in the central nervous system using in vitro and in vivo models.

Authors:  H Sun; D W Miller; W F Elmquist
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 4.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

5.  Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport.

Authors:  R Xie; M R Bouw; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 6.  Drug transporters, the blood-testis barrier, and spermatogenesis.

Authors:  Linlin Su; Dolores D Mruk; C Yan Cheng
Journal:  J Endocrinol       Date:  2010-12-06       Impact factor: 4.286

7.  Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.

Authors:  J Wijnholds; E C deLange; G L Scheffer; D J van den Berg; C A Mol; M van der Valk; A H Schinkel; R J Scheper; D D Breimer; P Borst
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

8.  Placental transfer and fetal elimination of morphine-3-beta-glucuronide in the pregnant baboon.

Authors:  Marianne Garland; Kirsten M Abildskov; Tung-Wah Kiu; Salha S Daniel; Piper Weldy; Raymond I Stark
Journal:  Drug Metab Dispos       Date:  2008-06-19       Impact factor: 3.922

9.  Expression and functional involvement of organic anion transporting polypeptide subtype 3 (Slc21a7) in rat choroid plexus.

Authors:  Hiroyuki Kusuhara; Zhonggui He; Yoshinori Nagata; Yoshitane Nozaki; Takashi Ito; Hiroyuki Masuda; Peter J Meier; Takaaki Abe; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

10.  Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood-cerebrospinal fluid barrier in human brain.

Authors:  Koichi Matsumoto; Yoichi Chiba; Ryuji Fujihara; Hiroyuki Kubo; Haruhiko Sakamoto; Masaki Ueno
Journal:  Histochem Cell Biol       Date:  2015-10-08       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.